In-hospital delay in ST-segment-elevation myocardial infarction after Manchester Triage

Joana Trigo1, Paula Gago, Jorge Mimoso

  • 1Serviço de Cardiologia, Hospital Central de Faro, Faro, Portugal. jotrigo@gmail.com

Insights

The Manchester Triage System (MTS) often misclassifies ST-segment elevation myocardial infarction (STEMI) patients, leading to significant in-hospital delays (IHD) and limiting timely reperfusion therapy.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Healthcare Systems Analysis

Background:

  • Timely reperfusion is critical for ST-segment elevation myocardial infarction (STEMI) patients, directly impacting morbidity and mortality.
  • Reducing in-hospital delay (IHD) remains a key objective in STEMI management.
  • The effectiveness of the Manchester Triage System (MTS) in expediting STEMI care is under scrutiny.

Purpose of the Study:

  • To assess the accuracy of the MTS in classifying STEMI patients.
  • To determine the impact of MTS classification on in-hospital delay (IHD) for STEMI patients.

Main Methods:

  • A retrospective analysis of 278 STEMI patients admitted to a Coronary Care Unit between January 2005 and November 2006.
  • Patients were categorized into two groups based on MTS classification: emergent/very urgent (Group A) and urgent/standard (Group B).
  • Comparison of clinical, demographic, pre-hospital delay (PHD), IHD, door-to-needle (DNT), and door-to-balloon (DBT) times between groups.

Main Results:

  • No significant differences in clinical characteristics or pre-hospital delay (PHD) were observed between the two MTS classification groups.
  • Patients in Group B (urgent/standard classification) experienced significantly longer in-hospital delays (IHD), door-to-needle (DNT), and door-to-balloon (DBT) times.
  • A substantial proportion of STEMI patients were not classified as emergent or very urgent by the MTS.

Conclusions:

  • The Manchester Triage System (MTS) demonstrated a high rate of suboptimal classification for STEMI patients.
  • Incorrect MTS classification was associated with significantly increased in-hospital delays (IHD).
  • Suboptimal triage by MTS can impede prompt access to crucial reperfusion therapies for STEMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...